SCHEMBL3392349

SCHEMBL3392349

O=C(c1[c]cc2ccccc2c1)N1CCC(n2nnc3ccccc32)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.59
MEN1 O00255 1/20 0.59
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59
KMT2A Q03164 1/20 0.59
ALDH1A1 P00352 7/20 0.58
USP2 O75604 4/20 0.58
KDM4E B2RXH2 1/20 0.51
MAPT P10636 1/20 0.51
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
LMNA P02545 4/20 0.46
TNKS O95271 1/20 0.46
PARP1 P09874 1/20 0.46
PARP2 Q9UGN5 1/20 0.46
JAK1 P23458 1/20 0.45
TSHR P16473 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
BAP1 Q92560 1/20 0.45
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5751254 0.76 ALDH1A1 (0.70) L3MBTL1MEN1NPC1RAB9AKMT2A
SCHEMBL3390119 0.76 HSD11B1 (0.60) CHRM4
SCHEMBL3393806 0.72 UBE2M (0.62) MEN1KMT2AALDH1A1MAPTHSD17B10
SCHEMBL27575531 0.72 HPGD (0.49) L3MBTL1MEN1NPC1RAB9AKMT2A
SCHEMBL3100293 0.71 FPR2 (0.63) L3MBTL1MEN1NPC1RAB9AKMT2A
SCHEMBL4405502 0.71 ALDH1A1 (0.62) L3MBTL1MEN1NPC1RAB9AKMT2A
SCHEMBL5633033 0.70 USP2 (0.58) L3MBTL1MEN1NPC1RAB9AKMT2A
SCHEMBL4777481 0.69 L3MBTL1 (0.61) L3MBTL1MEN1NPC1RAB9AKMT2A
Lithium Ion SCHEMBL5633232 0.69 USP2 (0.57) L3MBTL1MEN1NPC1RAB9AKMT2A
SCHEMBL825280 0.68 AVPR1A (0.67) L3MBTL1MEN1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1716160-B1 NOVEL INHIBITORS OF CHYMASE JANSSEN PHARMACEUTICA NV (BE) 2010-12-29 EP claimed
EP-1716160-B1 NOVEL INHIBITORS OF CHYMASE JANSSEN PHARMACEUTICA NV (BE) 2010-12-29 EP disclosed